Non-registered Executive Kim Jong-ho's Shares Reduced by 90% Due to Stock Merger, Ownership Ratio Unchanged, Neutral Impact on Shareholder Value


  • Non-registered executive Kim Jong-ho of Hwail Pharm saw his shareholding decrease by 14,610 shares from 16,233 to 1,623 due to a 10-to-1 stock merger on April 9, 2026.
  • The stock merger reduced total outstanding shares proportionally, leaving Kim's ownership ratio unchanged at 0.02%, thus no dilution of existing shareholder value.
  • This change is a routine regulatory filing with no capital raising or governance shifts, making it a neutral event for investors.
  • [AI Summary]The stock merger reduced the executive's holdings without altering ownership percentage, indicating no dilution or value transfer; the event is neutral for shareholder value with no additional funding or control changes.

KOSDAQ Filing Information


  • Report on Ownership of Specific Securities by Executives and Major Shareholders
  • Company: Hwail Pharm (061250)
  • Submission: Kim Jong-ho

  • Shares: 84,175,847
  • Price: 943 KRW
  • Market Cap: 79.4 B KRW